Reshma Kewalramani ranks 62 on Fortune's 2025 list of 100 Most Powerful People in Business She is the first woman to lead a major US biotechnology firm, Vertex Pharmaceuticals Vertex is valued at over $110 billion, known for cystic fibrosis and gene-editing therapies
